Your browser doesn't support javascript.
Clinical outcomes of SARS-CoV-2 infected people with diabetes who developed Severe Acute Respiratory Syndrome in Brazil / Desfecho clínico de pessoas com diabetes infectadas pelo SARS-CoV-2 que desenvolveram Síndrome Respiratória Aguda Grave, Brasil
Andrade, Caroline Marques de; Geumaro, Eduardo Alexandre; Borges, Felipe Abrantkoski; Jacomossi, Ângelo César Fernandes.
  • Andrade, Caroline Marques de; Centro Universitário Católico Salesiano Auxiliuma. Araçatuba. BR
  • Geumaro, Eduardo Alexandre; Centro Universitário Católico Salesiano Auxilium. Araçatuba. BR
  • Borges, Felipe Abrantkoski; Centro Universitário Católico Salesiano Auxilium. Araçatuba. BR
  • Jacomossi, Ângelo César Fernandes; Centro Universitário Católico Salesiano Auxilium. Araçatuba. BR
Medicina (Ribeirao Preto, Online) ; 55(3)set. 2022. tab, graf
Article in Portuguese | WHO COVID, LILACS (Americas) | ID: covidwho-2145219
Responsible library: BR26.1
RESUMO

Objetivo:

Comparar os desfechos clínicos de pessoas com e sem Diabetes Mellitus tipo 2 (DM 2), infectadas pelo SARS-CoV-2, que desenvolveram Síndrome Respiratória Aguda Grave (SRAG) no Brasil.

Métodos:

Trata-se de um estudo transversal realizado a partir de análise da ficha de notificação compulsória de Síndrome Respiratória Aguda Grave Hospitalizado, obtidas no DATASUS. Foram analisados homens e mulheres com e sem DM2, infectados pelo SARS-CoV-2 e notificados como SRAG no período de fevereiro de 2020 a maio de 2021. Foram identificados os desfechos hospitalização, admissão em Unidade de Terapia Intensiva (UTI) e óbito. Em seguida, a porcentagem de cada desfecho entre pessoas com DM2 foi comparada com a de pessoas não-diabéticas infectadas no mesmo período, utilizando o teste de Qui-Quadrado, com intervalo de confiança de 95%.

Resultados:

De um total de 384.805 pacientes, 111.046 eram diabéticos e 273.759 não diabéticos. Entre os diabéticos, 98.2% foram hospitalizados, 43.7% admitidos em UTI e 44.6% evoluíram a óbito. Enquanto entre os não-diabéticos, 97.3% necessitaram de hospitalização, 37.2% foram admitidos em UTI e 35.7% evoluíram a óbito. Após a análise com o teste de Qui-Quadrado, nos desfechos analisados foi encontrada uma diferença estatística significante (p<0.001) entre os grupos.

Conclusão:

A presença de DM 2 esteve associada a um pior prognóstico da COVID-19, quando comparada a pessoas sem DM2 na população brasileira. Entretanto, são necessários mais estudos para estabelecer a causalidade e elucidar a fisiopatologia dessa associação (AU)
ABSTRACT

Objective:

Compare the clinical outcomes of people with and without Type 2 Diabetes Mellitus (DM2), infected by SARS-CoV-2, who developed Severe Acute Respiratory Syndrome (SARS) in Brazil.

Methodology:

This is a cross-sectional study. The research was carried out by analyzing the compulsory notification form Severe Acute Respiratory Syndrome of hospitalized patients, obtained from DATASUS. Type 2 diabetic and non-diabetic men and women infected with SARS-CoV-2 and notified as SARS in the period February 2020 to May 2021 were analyzed. The outcomes were identified as hospitalization, Intensive Care Unit (ICU) admission, and death. The percentage of each outcome among diabetic patients was compared with that of the infected non-diabetic patients in the same period using the Chi-square test, with a 95% confidence interval.

Results:

From a total of 384,805 patients, 111,046 were diabetic and 273,759 non-diabetic. Among the diabetic patients, 98.2% were hospitalized, 43.7% were admitted to the ICU, and 44.6% died. While among non-diabetics, 97.3% required hospitalization, 37.2% were admitted to the ICU, and 35.7% died. After the analysis with the Chi-square test, a statistically significant difference was found between the groups (p<0.001).

Conclusion:

The presence of DM2 was associated with a worse prognosis for COVID-19 compared to people without DM2, in the Brazilian population. However, further studies are needed to establish causality and elucidate the pathophysiology of this association (AU)
Subject(s)
Keywords

Full text: Available Collection: International databases Database: WHO COVID / LILACS (Americas) Main subject: Chi-Square Distribution / Cross-Sectional Studies / Diabetes Mellitus / SARS-CoV-2 / COVID-19 / Intensive Care Units Type of study: Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Topics: Long Covid Country/Region as subject: South America / Brazil Language: Portuguese Journal: Medicina (Ribeirao Preto, Online) Journal subject: Medicina Year: 2022 Document Type: Article Institution/Affiliation country: Centro Universitário Católico Salesiano Auxilium/BR / Centro Universitário Católico Salesiano Auxiliuma/BR

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: WHO COVID / LILACS (Americas) Main subject: Chi-Square Distribution / Cross-Sectional Studies / Diabetes Mellitus / SARS-CoV-2 / COVID-19 / Intensive Care Units Type of study: Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Topics: Long Covid Country/Region as subject: South America / Brazil Language: Portuguese Journal: Medicina (Ribeirao Preto, Online) Journal subject: Medicina Year: 2022 Document Type: Article Institution/Affiliation country: Centro Universitário Católico Salesiano Auxilium/BR / Centro Universitário Católico Salesiano Auxiliuma/BR